Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Inspira Technologies Oxy BHN ( (IINN) ) has shared an update.
On September 11, 2025, Inspira Technologies announced that its HYLA blood sensor achieved 97.35% accuracy in its latest testing phase, marking a significant advancement from earlier clinical study data. This result supports the upcoming FDA submission for the device, which offers continuous, non-invasive monitoring and is compatible with various medical procedures. The HYLA sensor’s design aims to penetrate the broader disposables market, leveraging a recurring revenue model, and has attracted interest from leading global medtech companies.
The most recent analyst rating on (IINN) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Inspira Technologies Oxy BHN stock, see the IINN Stock Forecast page.
Spark’s Take on IINN Stock
According to Spark, TipRanks’ AI Analyst, IINN is a Underperform.
The overall stock score reflects significant financial instability, as indicated by ongoing losses and reliance on external funding. The technical analysis shows bearish sentiment, with the stock under pressure. Valuation is challenging due to negative earnings and lack of dividend yield, making the stock less appealing to investors.
To see Spark’s full report on IINN stock, click here.
More about Inspira Technologies Oxy BHN
Inspira Technologies is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions. The company offers the FDA-cleared INSPIRA ART100 system for cardiopulmonary bypass in the U.S. and ECMO procedures outside the U.S. Inspira is also advancing its proprietary HYLA blood sensor platform, which provides continuous, non-invasive monitoring. With multiple cleared products and a growing IP portfolio, Inspira is positioned as a significant player in the life-support and MedTech industry.
Average Trading Volume: 1,116,439
Technical Sentiment Signal: Buy
Current Market Cap: $32.02M
For detailed information about IINN stock, go to TipRanks’ Stock Analysis page.